Furthermore, in addition to its immune inhibitory effects, Gal-1 can also favor tumor development and progression through promotion of tumor angiogenesis, favoring vascular endothelial growth factor (VEGF) signaling, and promoting endothelial cell proliferation, adhesion, migration, and resistance to apoptosis (34, 74). The gene discussed is GAL; the disease is neoplasm.